ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Adaptimmune, TCR² Combine Forces, Incre
ScripVenture capital firms focused on biopharmaceutical companies raised $810m across two new funds during the past two weeks, including $550m for venBio and Ysios Capital’s recently closed €216m ($260m) f